机译:变构BCR-ABL1药物的曙光:从表型筛选到获批药物
Dana Farber Canc Inst;
Novartis Inst Biomed Res;
Allor TherapeutCellestia BiotechStanford Univ;
BCR-ABL KINASE; PATIENTS RECEIVING IMATINIB; CHRONIC MYELOID-LEUKEMIA; TYROSINE KINASE; C-ABL; CLINICAL RESISTANCE; SELECTIVE INHIBITOR; DOMAIN MUTATIONS; FAMILY KINASES; PAN-INHIBITOR;